Inventor · disambiguated record
Hugo Matern
Also filed as: MATERN HUGO
21 granted patents·4 pending applications·136 citations·filing 2014–2024
95Inventor score
Files withNGM BIOPHARMACEUTICALS INC25
Top patents by PatentIndex Score
25 records- 0197US9161966B2GDF15 mutein polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2014·Granted Oct 20, 2015·29 cites·25 claims
- 0296US10174119B2Binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·10 cites·43 claims
- 0396US9827291B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·16 cites·46 claims
- 0495US9920118B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Mar 20, 2018·19 cites·34 claims
- 0595US9738716B2Beta klotho binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·9 cites·6 claims
- 0693US10093735B2Beta-klotho binding proteinsNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·4 cites·15 claims
- 0792US10610568B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2020·5 cites·37 claims
- 0892US9828415B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2014·Granted Nov 28, 2017·17 cites·46 claims
- 0990US10323075B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 18, 2019·8 cites·34 claims
- 1089US11530260B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·2 cites·44 claims
- 1189US10744191B2Beta klotho-binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Aug 18, 2020·3 cites·28 claims
- 1288US10800843B2Beta klotho-binding proteinsNGM BIOPHARMACEUTICALS INC·Filed 2016·Granted Oct 13, 2020·3 cites·14 claims
- 1388US10562965B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Feb 18, 2020·5 cites·39 claims
- 1487US10975154B2Binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Apr 13, 2021·2 cites·56 claims
- 1587US2025188174A1Binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1686US11596676B2Methods of treating nonalcoholic steatohepatitis comprising administering an anti-human beta klotho antibody or binding fragment thereofNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Mar 7, 2023·1 cites·21 claims
- 1786US10995145B2Antibodies which bind human glucagon receptorNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted May 4, 2021·2 cites·29 claims
- 1885US11667708B2Anti-human beta klotho antibody or binding fragment thereof and methods of their useNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·1 cites·59 claims
- 1984US12378312B2Polynucleotides encoding human beta klotho antibodies or binding fragments thereof and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Granted Aug 5, 2025·0 cites·23 claims
- 2082US12173060B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 2178US2024084023A1Glucagon receptor binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2276US12180289B2Binding proteins and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Dec 31, 2024·0 cites·20 claims
- 2373US11732049B2Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptorNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Aug 22, 2023·0 cites·24 claims
- 2470US2021388047A1Compositions and Methods of Use for Treating Metabolic DisordersNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2561US2020087366A1Compositions and Methods of Use For Treating Metabolic DisordersNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hugo Matern files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →